As we can see, Axonics Modulation Technologies is performing better than its sector in the calendar year. Another Medical stock, which has outperformed the sector so far this year, is Molina (MOH). The stock has returned 10.4% year-to-date. The consensus estimate for Molina's current year EPS has increased 2.7% over the past three months. The stock currently has a Zacks Rank #2 (Buy). Looking more specifically, Axonics Modulation Technologies belongs to the Medical Info Systems industry, which includes 49 individual stocks and currently sits at #70 in the Zacks Industry Rank.